Seven Eight Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-70,697	Closed	-$1.79M	–	783
2023 Q2	$1.79M	Buy	70,697 +61,788	+694%	+$1.56M	0.3%	107
2023 Q1	$287K	Buy	+8,909	New	+$287K	0.06%	341
2020 Q2	–	Sell	-11,289	Closed	-$167K	–	595
2020 Q1	$167K	Buy	+11,289	New	+$167K	0.04%	414